Autologous blood transfusion - A review

South African Journal of Surgery

Volumn 44, Issue 3, 2006, Pages 114-118

  Adias, Teddy Charles ^a   Jeremiah, Zacheus ^a   Uko, Emmanuel ^b   Osaro, Erhabor ^c  

^a RIVERS STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Nigeria)

^b UNIVERSITY OF CALABAR   (Nigeria)

^c UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; CITRIC ACID; HEPARIN; HLA ANTIGEN;

BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD VISCOSITY; BLOOD VOLUME; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ERYTHROCYTE; HEALTH CARE COST; HEART OUTPUT; HEMODILUTION; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; NIGERIA; OXYGEN CONSUMPTION; PHLEBOTOMY; POSTOPERATIVE COMPLICATION; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

BLOOD BANKS; BLOOD TRANSFUSION, AUTOLOGOUS; DEVELOPING COUNTRIES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; NIGERIA; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; TRANSPLANTATION, HOMOLOGOUS;

EID: 33747590140     PISSN: 00382361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Blumberg N, Vanderlinde ES, Heal JM. Autologous transfusion. BMJ 2002; 324: 772-775.
2. Blumberg N, Heal JM. Effects of transfusion on immune function - cancer recurrence and infection. Arch Pathol Lab Med 1994; 118: 371-379.
3. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomised study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-1867.
4. Houbiers JG, van de Velde CJ, van de Watering LM, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997; 37: 126-134.
5. Sloand E, Kumar P, Klein HG, Merritt S, Sacher R. Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection. Transfusion 1994; 34: 48-53.
6. Kirkley SA. Proposed mechanisms of transfusion-induced immunomodulation. Clin Diagn Lab Immunol 1999; 6: 652-657.
7. Kirkley SA, Cowles J, Pellegrini VD, et al. Increased T helper 2 (Th2) type cytokine secretion in surgical patients receiving allogeneic transfusions. Transfus Med 1998; 8: 195-204.
8. Parker-Williams EJ. Autologous blood transfusion. Postgraduate Doctor 1989; 11: 52-56.
9. Kruskall MS. Autologous blood transfusion and related alternatives to allogeneic transfusion. In: Hillyer CD, Silberstein LE, Ness PM, et al. eds. Blood Banking and Transfusion Medicine. 1st ed. Philadelphia: Churchill Livingstone, 2003: 273-282.
10. Voak D, Finney RD, Forman P, et al. Guidelines for autologous transfusion. I. Preoperative autologous donation. British Committee for Standards in Haematology and Blood Transfusion Task Force. Autologous Transfusion Working Party. Transfus Med 1993; 3: 307-316.
11. Napier JA, Bruce M, Chapman J, et al. Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage. British Committee for Standards in Haematology and Blood Transfusion Task Force. Autologous Transfusion Working Party. Br J Anaesth 1997; 78: 768-771.
12. Brecher ME, Rosenfeld M. Mathematical and computer modeling of acute normovolaemic haemodilution. Transfusion 1994; 34: 176-179.
13. Monk TG, Goodnough LT, Brecher ME, et al. Acute normovolaemic haemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg 1997; 85: 953-958.
14. Weiskopf RB. Mathematical analysis of isovolaemic haemodilution indicates that it can decrease the need for allogeneic blood transfusion. Transfusion 1995; 35: 37-41.
15. Ness PM, Bourke DL, Walsh PC. A randomised trial of perioperative haemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion 1992; 89: 226-230.
16. Aaron RK, Beazley RM, Riggle GC. Haematologic integrity after intraoperative allotransfusion: Comparison with bank blood. Arch Surg 1974; 107: 831-837.
17. Brener BJ, Raines JK, Darling RC. Intraoperative autotransfusion in abdominal aortic resection. Arch Surg 1973; 107: 78-84.
18. Stillman RM, Wrezlewicz WW, Stanczewski BS, et al. The haematological hazards of autotransfusion. Br J Surg 1976; 63: 651-654.
19. Griffith LD, Billman EL, Breslich DJ, et al. Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. Ann Thorac Surg 1989; 47: 400-406.
20. Schmidt H, Mortensen PE, Folsgaard SL, Jensen EA. Cardiac enzyme and autotransfusion of shed mediastinal blood after myocardial revascularization. Ann Thorac Surg 1997; 63: 1288-1292.
21. Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion. A randomised controlled study after knee replacement. J Bone Joint Surg Br 1997; 79: 630-632.
22. Farrer A, Spark JI, Scott DJ. Autologous blood transfusion: the benefits to the patient undergoing abdominal aortic aneurysm repair. Journal of Vascular Nursing 1997; 15: 111-115.
23. Thomas D, Wareham K, Cohen D, Hutchings H. Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001; 86: 669-673.
24. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, et al. Blood transfusion and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-1376.
25. Goodnough LT, Monk TG, Despotis GJ, Merkel K. A randomised trial of acute normovolaemic haemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sang 1999; 77: 11-16.
26. Bryson GL, Laupacis A, Wells GA. Does acute normovolaemic haemodilution reduce perioperative allogeneic transfusion? A meta-analysis. Anesth Analg 1998; 86: 9-15.
27. Rosenblatt MA. Strategies for minimising the use of allogeneic blood during orthopaedic surgery. Mt Sinai J Med 2002; 69: 83-87.
28. Etchason J, Petz L, Keeler E, et al. The cost-effectiveness of preoperative autologous blood transfusion donation. N Engl J Med 1995; 332: 719-724.
29. Sonnenberg FA, Gregory P, Yomtovian R, et al. The cost-effectiveness of preoperative autologous blood transfusion revisited: Implication of an increased risk of bacterial infection with allogeneic transfusion. Transfusion 1995; 39: 808-817.